RE: DISAPPOINTMENT14 Mar 2024 10:06
Given the usual appalling comms we've no idea what's really going. The 'delay' could be recruitment and there's no way to fast track that. They're focussed in a particular area - you don't get ODD for common stuff. So there won't be a readily available pool of people with the particular cancer they're interested in, having been treated previously in a particular way that are willing to sign up for a trial in a particular group of hospitals. It's not difficult to imagine that numbers are small. Yeah, we could flog it / licence it (ink well is still full) and BP could run the trial in more sites, but it's not getting to market overnight, you can't shortcut trials. We can see that from the 1b phase (now named as "leading up to P2") that's reappeared in the (nonsense) timelines from nowhere (thanks for the comms Al).